跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
liver-targeting interferon
首页
药物
liver-targeting interferon
liver-targeting interferon
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
RNA INHIBITOR FOR INHIBITING HEPATITIS B VIRUS GENE EXPRESSION AND APPLICATION THEREOF
EP 4324923 A4
申请人: KYLONOVA XIAMEN BIOPHARMA CO LTD
优先权: 2021
CN
EP
WO
6 件公开
Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes
US 2010098748 A1
申请人: WANG JIYAO
优先权: 2005
CN
US
2 件公开
Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines
US 8481075 B2
申请人: XIAOPING LI
优先权: 2007
US
2 件公开
Preparation and use of galactosylated human serum albumin fused interferon
CN 101328220 A
申请人: JIANGSU INST OF NUCLEAR MED
优先权: 2008
CN
Method for molecular modification of liver-targeting interferon, and mutant liver-targeting interferon
CN 105602976 A
申请人: UNIV GUANGDONG PHARM
优先权: 2015
CN
Fusion protein as well as preparation method and application thereof
CN 108219003 A
申请人: UNIV SOUTH CHINA
优先权: 2018
CN
External medicine capable of resisting HPV infection and converting HPV positive into HPV negative and preparation method thereof
CN 113908218 A
申请人: GU SHAOYA
优先权: 2020
CN
Application of liver targeting gamma-interferon expression vector in preparation of drugs for treating and resisting liver tumors
CN 114470241 A
申请人: MIDDLE DAY FRIENDLY HOSPITAL MIDDLE DAY FRIENDLY CLINICAL MEDICINE RES INSTITUTE
优先权: 2022
CN
Application of 18S rRNA m7G modified inhibitor in sensitization of PD1 in treatment of liver cancer
CN 121695276 A
申请人: THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
优先权: 2025
CN
药物
反馈